[HTML][HTML] Real-time genomic surveillance for SARS-CoV-2 variants of concern, Uruguay
…, M Méndez, MP Techera, J Zanetti… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We developed a genomic surveillance program for real-time monitoring of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in Uruguay. We …
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in Uruguay. We …
[HTML][HTML] Emergence and spread of a B. 1.1. 28-derived P. 6 lineage with Q675H and Q677H spike mutations in Uruguay
…, L Griffero, M Méndez, MP Techera, J Zanetti… - Viruses, 2021 - mdpi.com
Uruguay controlled the viral dissemination during the first nine months of the SARS-CoV-2
pandemic. Unfortunately, towards the end of 2020, the number of daily new cases …
pandemic. Unfortunately, towards the end of 2020, the number of daily new cases …
Spatiotemporal dissemination pattern of SARS-CoV-2 B1. 1.28-derived lineages introduced into Uruguay across its southeastern border with Brazil
…, I Arantes, V Noya, D Mir, M Brandes, J Zanetti… - medRxiv, 2021 - medrxiv.org
During the first nine months of the SARS-CoV-2 pandemic, Uruguay successfully kept it
under control, even when our previous studies support a recurrent viral flux across the …
under control, even when our previous studies support a recurrent viral flux across the …
Implementation of a qPCR assay coupled with genomic surveillance for real-time monitoring of SARS-CoV-2 variants of concern
…, L Griffero, M Méndez, MP Techera, J Zanetti… - medRxiv, 2021 - medrxiv.org
We developed a genomic surveillance program for real-time monitoring of SARS-CoV-2
variants of concern in Uruguay. Here, we present the first results, including the proposed qPCR-…
variants of concern in Uruguay. Here, we present the first results, including the proposed qPCR-…
[HTML][HTML] A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL
SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera… - Molecular Therapy, 2022 - cell.com
CD19-directed chimeric antigen receptor (CAR) T cells have yielded impressive response
rates in refractory/relapse B cell acute lymphoblastic leukemia (B-ALL); however, most …
rates in refractory/relapse B cell acute lymphoblastic leukemia (B-ALL); however, most …
CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
…, M Sorigué, P Bárcena, SR Zanetti… - Blood, The Journal …, 2022 - ashpublications.org
CD19-directed immunotherapies have revolutionized the treatment of advanced B-cell acute
lymphoblastic leukemia (B-ALL). Despite initial impressive rates of complete remission (CR…
lymphoblastic leukemia (B-ALL). Despite initial impressive rates of complete remission (CR…
[HTML][HTML] Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity
SR Zanetti, PA Romecin, M Vinyoles… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Although adoptive transfer of CD19-directed chimeric antigen receptor (CAR) T-cells
(CD19-CAR T-cells) achieves high rates of complete response in patients with B-cell …
(CD19-CAR T-cells) achieves high rates of complete response in patients with B-cell …
Overcoming CAR-mediated CD19 downmodulation and leukemia relapse with T lymphocytes secreting anti-CD19 T-cell Engagers
…, F Gutierrez-Agüera, SR Zanetti… - Cancer immunology …, 2022 - AACR
… Samanta Romina Zanetti … Patricia Fuentes, Óscar Aguilar-Sopeña, Francisco Gutierrez-Agüera,
Samanta Romina Zanetti, Antonio Tapia-Galisteo, Laura Díez-Alonso, Alejandro Segura-…
Samanta Romina Zanetti, Antonio Tapia-Galisteo, Laura Díez-Alonso, Alejandro Segura-…
Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection
…, B Estifanos, J Enow, IR Zanetti… - EMBO molecular …, 2023 - embopress.org
SARS‐CoV‐2 acute respiratory distress syndrome (ARDS) induces uncontrolled lung
inflammation and coagulopathy with high mortality. Anti‐viral drugs and monoclonal antibodies …
inflammation and coagulopathy with high mortality. Anti‐viral drugs and monoclonal antibodies …
Enforced sialyl‐Lewis‐X (sLeX) display in E‐selectin ligands by exofucosylation is dispensable for CD19‐CAR T‐cell activity and bone marrow homing
CD19‐directed chimeric antigen receptors (CAR) T cells induce impressive rates of
complete response in advanced B‐cell malignancies, specially in B‐cell acute lymphoblastic …
complete response in advanced B‐cell malignancies, specially in B‐cell acute lymphoblastic …